The use of in vitro expanded human CNS precursors has the potential to over
come some of the ethical, logistic and technical problems of fetal tissue t
ransplantation in Parkinson disease. Cultured rat mesencephalic precursors
proliferate in response to bFGF and upon mitogen withdrawal, differentiate
into functional dopamine neurons that alleviate motor symptoms in Parkinson
ian rats (Studer et al. [1998] Nat. Neurosci. 1:290-295). The successful cl
inical application of CNS precursor technology in Parkinson disease will de
pend on the efficient in vitro generation of human dopaminergic neurons. We
demonstrate that human dopamine neurons can be generated from both midbrai
n and cortical precursors. Transplantation of midbrain precursor-derived do
pamine neurons into Parkinsonian rats resulted in grafts rich in tyrosine h
ydroxylase positive neurons 6 weeks after transplantation. No surviving tyr
osine hydroxylase positive neurons could be detected when dopamine neurons
derived from cortical precursors were grafted. Our data demonstrate in vitr
o derivation of human dopamine neurons from expanded CNS precursors and enc
ourage further studies that systematically address in vivo function and cli
nical potential. (C) 2001 Wiley-Liss, Inc.